Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00438204 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped All data collection has completed.

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: gemcitabine hydrochloride
DRUG: pemetrexed disodium

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]